摘要
The present study was designed to examine the effects of atorvastatin on vascular inflammatory responses in human coronary artery endothelial cells(HCAECs), when challenged by lipopolysaccharide (LPS), a Toll-like receptor-4 (TLR4) ligand. HCAECs were pretreated with atorvastatin and induced by LPS. The expression of TLR4, interleukin -6(IL-6), monocyte chemoattractant protein 1(MCP-1), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecular-1(ICAM-1), nuclear factor-kappa B (NF-kappa B) and p38 mitogen activated protein kinase(p38 MAPK) were evaluated using Real-time polymerase chain reaction, cytokine ELISA assay and Western blotting. The results showed that pretreatment with atorvastatin down-regulated the expression of TLR4 in LPS-activated HCAECs. Atorvastatin also attenuated the LPS-induced expression of interleukin IL-6 and MCP-1, at both the transcription and translation level in HCAECs. LPS-induced endothelial cell adhesion molecules, ICAM-1 and VCAM-1 expression were also reduced by pretreatment with atorvastatin. Furthermore, atorvastatin efficiently suppressed LPS-induced phosphorylation of NF-kappa B and p38 MAPK in HCAECs. These findings show that atorvastatin suppresses endothelial cell inflammation, suggesting that atorvastatin may be suitable for development as a therapeutic agent for inflammatory cardiovascular disease.
学科与关键词
- Inhibition of EphA2 protects against atherosclerosis by synergizing with statins to mitigate macrophage inflammationZeng, Jie; Wu, Qiao; Xiong, Shiqiang; Lu, Cong; Zhang, Zheng; Huang, Hui; Xiong, Yan; Luo, Tiantian*Biomedicine and Pharmacotherapy, 2023, 169: 115885.
- 阿托伐他汀通过下调PAPP-A、MMP3 mRNA表达抑制rhCRP诱导的人动脉平滑肌细胞炎症反应廖丽贞; 唐凯; 梅卫义; 陆立鹤广州医学院学报, 2013, (06): 10-14.
- Effects of Rosuvastatin on Fibrinolytic System of Human Umbilical Vein Endothelial Cells In VitroHe Fei*; Zhao Jing; Guo Rong; Liang YingAMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 348(4): 319-323.
